Cullinan Therapeutics, Inc. (CGEM)
10.17
-0.02
(-0.20%)
USD |
NASDAQ |
Nov 13, 10:38
Cullinan Therapeutics Free Cash Flow (Quarterly) : -43.08M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -43.08M |
| June 30, 2026 | -38.22M |
| March 31, 2026 | -46.04M |
| December 31, 2025 | -38.12M |
| September 30, 2025 | -36.88M |
| June 30, 2025 | -57.61M |
| March 31, 2025 | -43.16M |
| December 31, 2024 | -36.63M |
| September 30, 2024 | -34.14M |
| June 30, 2024 | -36.29M |
| March 31, 2024 | -38.25M |
| December 31, 2023 | -18.13M |
| September 30, 2023 | -34.14M |
| June 30, 2023 | -31.06M |
| Date | Value |
|---|---|
| March 31, 2023 | -51.16M |
| December 31, 2022 | -25.86M |
| September 30, 2022 | -54.60M |
| June 30, 2022 | -25.42M |
| March 31, 2022 | -21.91M |
| December 31, 2021 | -15.17M |
| September 30, 2021 | -10.55M |
| June 30, 2021 | -16.20M |
| March 31, 2021 | -1.515M |
| December 31, 2020 | -9.435M |
| September 30, 2020 | -9.075M |
| June 30, 2020 | -6.254M |
| March 31, 2020 | -5.018M |
| December 31, 2019 | -4.874M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Climb Bio, Inc. | -12.82M |
| MapLight Therapeutics, Inc. | -44.89M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |